CINV: cannabis' place in modern antiemetic care
Certain cannabinoids may be considered as an add-on when nausea and vomiting persist despite guideline-concordant prevention. The 2024 ASCO guideline describes this limited role for adults receiving chemotherapy. This is neither a recommendation for self-treatment nor evidence that cannabis treats the cancer itself.
TL;DR
- Certain cannabinoids may be considered as an add-on when nausea and vomiting persist despite guideline-concordant prevention. The 2024 ASCO guideline describes this limited role for adults receiving chemotherapy. This is neither a recommendation for self-treatment nor evidence that cannabis treats the cancer itself.
What the research actually shows
The ASCO recommendation concerns symptoms that persist despite appropriate antiemetic care. It is not a general recommendation for every cause of nausea. Possible relief of nausea also does not establish treatment of weight loss, tumour growth or every symptom experienced during cancer care.
What this means for treatment
Tell the oncology team when symptoms begin after treatment, which medicines have been used and whether eating, drinking and taking medication remain possible. Prevention and treatment of an acute episode are different tasks. Any add-on must fit the cancer treatment and accompanying medicines; a universal ranking or fixed dose would be misleading.
Risks and questions for your appointment
Tell your treatment team about every cannabis and CBD product. They can assess interactions, drowsiness and other risks within the whole treatment plan. Persistent vomiting or inability to keep fluids down warrants prompt contact with the team. Do not independently replace planned cancer treatment with cannabis.
Swiss rules and reimbursement: separate assessments
Since August 2022, medical prescribing of cannabis medicines no longer requires an exceptional FOPH permit. This does not establish authorisation for every condition or automatic reimbursement. The preparation, indication and applicable reimbursement rules need separate assessment.
Diagnostic records, previous treatment attempts and an up-to-date medication list are more useful for an appointment than a preferred product name. Record the everyday difficulties you hope to improve, remaining uncertainties and who will monitor outcomes and tolerability. Club membership does not replace medical assessment.
FAQ
Does less nausea mean an effect against the tumour?
No. Symptom relief and tumour treatment are different goals. Antiemetic research cannot support recommending cannabis as a standalone cancer treatment.
Does a prescription guarantee reimbursement?
No. Prescribing, medicine authorisation and reimbursement are separate questions. Clarify which rules apply to the preparation and indication, including whether prior reimbursement approval is needed.